Li, S., Zhao, J., Lv, L., & Dong, D. (2021). Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma. Frontiers in oncology, 11, 762821. https://doi.org/10.3389/fonc.2021.762821
Chicago Style (17th ed.) CitationLi, Shuai, Jingyuan Zhao, Linlin Lv, and Deshi Dong. "Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma." Frontiers in Oncology 11 (2021): 762821. https://doi.org/10.3389/fonc.2021.762821.
MLA (9th ed.) CitationLi, Shuai, et al. "Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma." Frontiers in Oncology, vol. 11, 2021, p. 762821, https://doi.org/10.3389/fonc.2021.762821.